Bluegrass Epilepsy Research, LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Epilepsy6 trials

Phase

• Phase 34 trials
• Phase 21 trial
• Phase 41 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Xenon Pharmaceuticals Inc.3 trials
• SK Life Science, Inc.2 trials
• Takeda1 trial

Running trials

• Active, not recruiting

  Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

  NCT06453213· Phase 4· SK Life Science, Inc.· Source

• Enrolling by invitation

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Recruiting

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· Phase 3· Xenon Pharmaceuticals Inc.· Source

  Contact: Xenon Medical Affairs

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy2 recruiting

Closed trials

• Completed

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

  NCT05614063· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Recruiting

  Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  NCT05219617· Phase 3· SK Life Science, Inc.· Source

  Contact: Barbara Remes

• Terminated

  A Study of Soticlestat in Adults and Children With Rare Epilepsies

  NCT03635073· Phase 2· Takeda· Source